This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: In vitro
screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives
CDKN1
and
..., Journal of Enzyme Inhibition and Medicinal Chemistry, May 2026, Taylor & Francis,
DOI: 10.1080/14756366.2026.2638836.
You can read the full text:
The following have contributed to this page
